Toggle light / dark theme

The cocktail, now named REGN-COV2, consists of two antibodies—REGN10933 and REGN10987—that are designed to bind non-competitively to the receptor binding domain of SARS-CoV-2’s spike protein. Regeneron says that such binding diminishes the ability of mutant viruses to escape treatment—with details from preclinical research to be published in upcoming research studies.


Regeneron Pharmaceuticals said today it has launched the first clinical trial of its dual-antibody “cocktail” designed to both prevent and treat COVID-19, as well as prevent viral escape. The cocktail, now named REGN-COV2, consists of two antibodies—REGN10933 and REGN10987—that are designed to bind non-competitively to the receptor binding domain of SARS-CoV-2’s spike protein. [Regeneron].

Chemistry Nobel

Olof Ramström, from the Nobel Committee, said lithium-ion batteries had “enabled the mobile world”.


Three scientists have been awarded the 2019 Nobel Prize in Chemistry for the development of lithium-ion batteries.

John B Goodenough, M Stanley Whittingham and Akira Yoshino share the prize for their work on these rechargeable devices, which are used for portable electronics.

CLEW, an Israeli medtech firm specializing in real-time AI analytics platforms, received approval from the United States Food and Drug Administration (FDA) for its “Predictive Analytics Platform in Support of COVID-19 Patients,” the company announced Tuesday.

The Intensive Care Unit (ICU) solution was given Emergency Use Authorization (EUA) by the FDA so that it may be implemented within the United States’ health system as soon as possible.

Intel Corporation announced Monday that its forthcoming Tiger Lake processors will pack a defense mechanism against Spectre-type malware attacks.

Spectre vulnerabilities allowed hackers to break into systems using Intel processors manufactured over two decades and steal passwords, personal photos, emails and other sensitive data stored in the memory of other running programs.

Such hijacking attacks have always been difficult to mitigate through . Intel’s new Control-Flow Enforcement Technology (Intel CET) will install CPU-level defense mechanisms to combat such assaults.